Literature DB >> 2139310

Herniated lumbar intervertebral disk.

R A Deyo1, J D Loeser, S J Bigos.   

Abstract

Low back pain is common, but a herniated intervertebral disk is the cause in only a small percentage of cases. Most symptomatic disk herniations result in clinical manifestations (pain, reflex loss, muscle weakness) that resolve with conservative therapy, and only 5% to 10% of patients require surgery. Sciatica is usually the first clue to disk herniation, but sciatica may be mimicked by other disorders that cause radiating pain. Because more than 95% of lumbar disk herniations occur at the L4-5 or L5-S1 levels, the physical examination should focus on abnormalities of the L5 and S1 nerve roots. Plain radiography is not useful in diagnosing disk herniation, but more sophisticated imaging (myelography, computed tomography, or magnetic resonance imaging) should generally be delayed until a patient is clearly a surgical candidate. Conservative therapy includes nonsteroidal anti-inflammatory drugs, brief bed rest (often for less than 1 week), early progressive ambulation, and reassurance about a favorable prognosis. Muscle relaxants and narcotic analgesics have a limited role, and their use should be strictly time-limited. Conventional traction and corsets are probably ineffective. Except for patients with the cauda equina syndrome, surgery is generally appropriate only when there is a combination of definite disk herniation shown by imaging, a corresponding syndrome of sciatic pain, a corresponding neurologic deficit, and a failure to respond to 6 weeks of conservative therapy.

Entities:  

Mesh:

Year:  1990        PMID: 2139310     DOI: 10.7326/0003-4819-112-8-598

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  30 in total

1.  The relation between expectations and outcomes in surgery for sciatica.

Authors:  G K Lutz; M E Butzlaff; S J Atlas; R B Keller; D E Singer; R A Deyo
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

2.  Industrial back belts and low back pain: Mechanisms and outcomes.

Authors:  B A Barron; M Feuerstein
Journal:  J Occup Rehabil       Date:  1994-09

3.  Trends in hospital use for mechanical neck and back problems in Ontario and the United States: discretionary care in different health care systems.

Authors:  J N Lavis; A Malter; G M Anderson; V M Taylor; R A Deyo; C Bombardier; T Axcell; W Kreuter
Journal:  CMAJ       Date:  1998-01-13       Impact factor: 8.262

4.  The relationship between morphology of lumbar disc herniation and MRI changes in adjacent vertebral bodies.

Authors:  Hamed Reyhani Kermani; Ehsan Keykhosravi; Masoud Mirkazemi; Mohammad R Ehsaei
Journal:  Arch Bone Jt Surg       Date:  2013-12-15

5.  Surgery for herniated lumbar discs: a literature synthesis.

Authors:  R M Hoffman; K J Wheeler; R A Deyo
Journal:  J Gen Intern Med       Date:  1993-09       Impact factor: 5.128

6.  Low back pain in the workplace: attainable benefits not attained.

Authors:  W O Spitzer
Journal:  Br J Ind Med       Date:  1993-05

Review 7.  Stem Cell Therapies for Treatment of Discogenic Low Back Pain: a Comprehensive Review.

Authors:  Ivan Urits; Alexander Capuco; Medha Sharma; Alan D Kaye; Omar Viswanath; Elyse M Cornett; Vwaire Orhurhu
Journal:  Curr Pain Headache Rep       Date:  2019-07-29

Review 8.  Evaluating and managing acute low back pain in the primary care setting.

Authors:  S J Atlas; R A Deyo
Journal:  J Gen Intern Med       Date:  2001-02       Impact factor: 5.128

9.  Utilization of medical services for the treatment of acute low back pain: conformance with clinical guidelines.

Authors:  W S Schroth; J M Schectman; E G Elinsky; J C Panagides
Journal:  J Gen Intern Med       Date:  1992 Sep-Oct       Impact factor: 5.128

10.  Risk factors for back pain-related loss of working time after surgery for lumbar disc herniation: a 5-year follow-up study.

Authors:  K Puolakka; J Ylinen; M H Neva; H Kautiainen; A Häkkinen
Journal:  Eur Spine J       Date:  2007-11-23       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.